NCT00125736View on ClinicalTrials.gov

A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

PHASE4CompletedINTERVENTIONAL

Enrollment

520

Participants

Timeline

Start Date

August 1, 2005

Primary Completion Date

April 19, 2007

Study Completion Date

April 19, 2007

Conditions

Stomach Ulcer

Interventions

DRUG

E0671

One 50 mg capsule is orally administered three times daily (150 mg/day)

DRUG

rabeprazole sodium

One 10mg tablet is administered orally each day

DRUG

E0671 placebo

One 50 mg capsule is orally administered three times daily (150 mg/day)

Trial Locations (43)

Unknown

Kariya

Nagoya

Seto

Toyoake

Toyohashi

Akita

Urayasu

Niihama

Chikushino-shi

Fukoka

Kurume

Oumuta

Tagawa

Sabae

Hashima

Asahikawa

Sapporo

Miki

Kanazawa

Kumamotoi

Sendai

Kashihara

Nigata

Yufu

Ikeda

Izumisano

Kadoma

Takatsuki

Hasuda

Kitaadachi-gun

Matsue

Hamamatsu

Minato-ku

Shinagawa-ku

Shinjyuku-ku

Shimonoseki

Gifu

Hiroshima

Kouchi

Kyoto

Nara

Ōita

Saga

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT00125736 - A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium | Biotech Hunter | Biotech Hunter